DGAP-Adhoc: MediClin AG: Volker Feldkamp will be successor of Frank Abele

MediClin AG / Key word(s): Change of Personnel

29.08.2013 11:45

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Ad hoc-Release according § 15 WpHG

Volker Feldkamp will be successor of Frank Abele

Offenburg, August 29, 2013 - The Supervisory Board of MEDICLIN
Aktiengesellschaft (MediClin) has appointed Volker Feldkamp (54) to the
Management Board of the Company effective January 1, 2014. He will be the
successor of Frank Abele (CEO), who will leave MediClin at the end of the
year 2013 at his own request. The Supervisory Board ensures by the
appointment of Volker Feldkamp at an early stage a smooth transition of the
tasks in the Management Board of MediClin.

Volker Feldkamp, before member of the Management Board of Rhön-Klinikum AG,
will head the Company as CEO after the resignation of Frank Abele. Volker
Feldkamp has many years of experience in the health care system as
executive manager and in the implementation of operational processes, so
that a continuous development of the existing strategy of the Company will
be guaranteed.

About MediClin AG (Ticker: MED; WKN: 659 510)

MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34
clinics and 7 nursing care facilities and 11 Medizinische
Versorgungszentren (medical care units) in 11 federal states MediClin has a
total capacity of approximately 8,100 beds. MediClins' facilities include
acute care clinics, i.e., general hospitals, special treatment facilities,
specialised hospitals and clinics for post-acute treatment and medical
rehabilitation. MediClin has approximately 8,500 employees.
MediClin ? a company of the Asklepios Group.

---------------------------------------------------------------------------

Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: alexandra.muehr@mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, München, Stuttgart

End of Announcement DGAP News-Service

---------------------------------------------------------------------------